Search Results - "Megerlin, F"

Cov19, seroprevalence studies and Individuals Protection Committees: aren't the technological and organizational challenges enough ? by Huriet, C, Megerlin, F

Get more information

Faecal microbiota transplantation: a sui generis biological drug, not a tissue by Megerlin, F, Fouassier, E, Lopert, R, Bourlioux, P

“…Responding to Smith et al. (Nature, 2014), this paper argues that for medical use, faecal microbiota transplantation (FMT) should be considered a sui generis…”
Get more information

Benefits of pharmacist-led flu vaccination services in community pharmacy by Kirkdale, C L, Nebout, G, Megerlin, F, Thornley, T

“…Seasonal influenza is a major cause of excess winter deaths and increased hospital admissions. There is a high level of economic burden associated with the…”
Get more information

Implementation of flu vaccination in community pharmacies: Understanding the barriers and enablers by Kirkdale, C L, Nebout, G, Taitel, M, Rubin, J, Jacinto, I, Horta, R, Megerlin, F, Thornley, T

“…Improving influenza vaccination coverage has been, and still remains a challenge internationally. There are now many examples where countries have pursued a…”
Get more information

Conditional pricing for innovative medicines in France: stop telling about risk-sharing! by Megerlin, F

“…Across global borders and throughout the various sectors of health care, the search for viable methods to pay for value has intensified. Driven by soaring…”
Get more information

Vaccination and French community pharmacists: from innovative actions to innovative organisations? by Megerlin, F

“…The situation report of vaccination in France and a methodology of vaccination suggests that some vaccines may opportunely be injected in the pharmacy where…”
Get more information

Faecal microbiota transplantation in France: what applicable law? by Megerlin, F, Fouassier, E

“…The transplantation of gut microbiota addresses a critical gap in the treatment of recurrent severe Clostridium difficile infection, and clinical trials are…”
Get more information

Fecal microbiota transplantation in recurrent Clostridium difficile infections. Framework and pharmaceutical preparation aspects by Batista, R, Kapel, N, Megerlin, F, Chaumeil, J-C, Barbut, F, Bourlioux, P, Chast, F

“…The fecal microbiota transplantation consists in introducing a preparation constituted by a dilution of stools of a healthy donor in the digestive tract of a…”
Get more information

Du lien d’intérêt au conflit d’intérêts by Megerlin, F.

“…Reflections on “conflict of interest” aim to promote and protect the independence of experts and health care providers against considerations that could…”
Get full text

Why could gut microbiota become a medication? by Bourlioux, P, Megerlin, F, Corthier, G, Gobert, J-G, Butel, M-J

“…The gut microbiota (or gut flora) is a set of bacteria living in symbiosis with the host. Strictly associated with the intestinal tract and interacting with…”
Get more information

Community pharmacist and vaccination: actuality and opportunity by Moreau, R, Lepage, H, Blanchet, F, Megerlin, F

“…Improving the vaccinal policy has become a major stake in France as in many other developed countries. The neglect of vaccination strategies by citizens has…”
Get more information

Du lien d'intérêt au conflit d'intérêts : Les conflits d'intérêts by MEGERLIN, F

Get full text

Comment interpréter l'« absence de spécialité disponible ou adaptée » dans le droit français des préparations à l'hôpital ? by MEGERUN, F

Get full text